Pattern of development of hyperprolactinemia after initiation of haloperidol therapy

Obstetrics and Gynecology

Volumn 91, Issue 5, 1998, Pages 693-695

  Spitzer, Mark ^a   Sajjad, Rehana ^a   Benjamin, Fred ^a  

^a QUEENS HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL;

ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HYPERPROLACTINEMIA; HYPOTHYROIDISM; MALE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; THYROTROPIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; FEMALE; HALOPERIDOL; HUMANS; HYPERPROLACTINEMIA; MALE; MIDDLE AGED; PROLACTIN; THYROTROPIN;

EID: 0031970252     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1016/s0029-7844(98)00066-0     Document Type: Article

References (8)

1. Anden NE, Dahlstrom A, Fuxe K, Hokfezt T. The effect of haloperidol and chlorpromazine on the amine levels of central monoamine neurons. Acta Physiol Scand 1966;68:419-420.
2. Kletzky OA, Davajan V. Hyperprolactinemia: Diagnosis and treatment. In: Mishell DR, Davajan V, eds. Infertility, reproductive endocrinology, and contraception. 2nd ed. Oradell, New Jersey: Medical Economic Books, 1986:275-301.
3. Oseko F, Morikawa K, Motohashi T, Aso T. Effects of chronic sulpiride-induced hyperprolactinemia on menstrual cycles of normal women. Obstet Gynecol 1988;72:267-271.
4. Tolis G, Hickey J, Guyda H. Effects of morphine on serum growth hormone, cortisol, prolactin, and thyroid-stimulating hormone in man. J Clin Endocrinol Metab 1975;41:797-800.
5. Raymond V, Beaulieu M, Labrie F, Bossier J. Potent antidopaminergic activity of estradiol at the pituitary level on prolactin release. Science 1978;200:1173-1175.
6. Feek CM, Sawers JSA, Brown NS, Seth J, Irvine WJ, Toft AD. Influence of thyroid status on dopaminergic inhibition of TSH and PRL secretion: Evidence for an additional feedback mechanism in the control of thyroid hormone secretion. J Clin Endocrinol Metab 1980;51:585-589.
7. Stein AL, Levenick MN, Kletzky OA. Computer tomography versus magnetic resonance imaging for the evaluation of suspected pituitary adenomas. Obstet Gynecol 1989;73:996-999.
8. Klibanski A, Neer RM, Beitens IZ, Ridgway EC, Zervas NT, McArthur JW. Decreased bone density in hyperprolactinemic women. N Engl J Med 1980;303:1511-1514.